DORE, Maria Pina
 Distribuzione geografica
Continente #
NA - Nord America 14.446
AS - Asia 8.762
SA - Sud America 4.972
EU - Europa 4.891
Continente sconosciuto - Info sul continente non disponibili 786
AF - Africa 318
OC - Oceania 35
Totale 34.210
Nazione #
US - Stati Uniti d'America 14.139
BR - Brasile 4.411
SG - Singapore 3.495
CN - Cina 2.536
UA - Ucraina 1.517
HK - Hong Kong 862
DE - Germania 688
IT - Italia 684
VN - Vietnam 645
SE - Svezia 609
FR - Francia 362
GB - Regno Unito 242
FI - Finlandia 229
AR - Argentina 207
BD - Bangladesh 163
TR - Turchia 138
IN - India 137
RU - Federazione Russa 118
CA - Canada 115
IQ - Iraq 113
MX - Messico 105
ZA - Sudafrica 96
EC - Ecuador 87
KR - Corea 86
PK - Pakistan 77
UZ - Uzbekistan 72
MA - Marocco 69
VE - Venezuela 66
AT - Austria 64
CO - Colombia 61
JP - Giappone 59
BE - Belgio 58
PL - Polonia 52
ID - Indonesia 48
ES - Italia 46
NL - Olanda 41
PY - Paraguay 38
KE - Kenya 37
JO - Giordania 33
UY - Uruguay 33
AU - Australia 30
AZ - Azerbaigian 30
CL - Cile 29
CZ - Repubblica Ceca 28
NP - Nepal 28
AE - Emirati Arabi Uniti 24
DZ - Algeria 24
PE - Perù 22
TN - Tunisia 22
KG - Kirghizistan 21
KZ - Kazakistan 21
RO - Romania 19
SA - Arabia Saudita 18
BO - Bolivia 17
EG - Egitto 17
IL - Israele 16
JM - Giamaica 16
OM - Oman 16
RS - Serbia 16
DO - Repubblica Dominicana 15
IR - Iran 15
IE - Irlanda 14
LT - Lituania 14
PH - Filippine 13
PS - Palestinian Territory 13
EU - Europa 12
MY - Malesia 12
AL - Albania 11
HN - Honduras 11
BA - Bosnia-Erzegovina 9
BG - Bulgaria 9
LB - Libano 9
NI - Nicaragua 9
XK - ???statistics.table.value.countryCode.XK??? 9
AM - Armenia 8
BY - Bielorussia 8
CR - Costa Rica 8
GR - Grecia 8
GE - Georgia 7
MD - Moldavia 7
MN - Mongolia 7
PA - Panama 7
QA - Qatar 7
SN - Senegal 7
A2 - ???statistics.table.value.countryCode.A2??? 6
BH - Bahrain 6
ET - Etiopia 6
GT - Guatemala 6
HU - Ungheria 6
NG - Nigeria 6
SV - El Salvador 6
BN - Brunei Darussalam 5
CI - Costa d'Avorio 5
GA - Gabon 5
PT - Portogallo 5
SK - Slovacchia (Repubblica Slovacca) 5
TH - Thailandia 5
HR - Croazia 4
LV - Lettonia 4
NZ - Nuova Zelanda 4
Totale 33.385
Città #
Dallas 3.846
Singapore 1.918
Chandler 1.544
San Jose 1.287
Jacksonville 906
Hong Kong 846
Ashburn 673
Beijing 531
Princeton 523
Council Bluffs 456
Columbus 407
Nanjing 382
São Paulo 327
Dearborn 320
Lauterbourg 265
Wilmington 233
Ho Chi Minh City 220
Shanghai 211
Santa Clara 193
Hanoi 151
New York 149
Los Angeles 148
Ann Arbor 141
Nanchang 135
Rio de Janeiro 117
Boardman 114
Sassari 107
Belo Horizonte 106
The Dalles 91
Brasília 87
Seoul 82
Curitiba 81
Tianjin 77
Helsinki 76
Hebei 75
Shenyang 72
Milan 67
Tashkent 64
Orem 62
Changsha 57
Porto Alegre 56
Tokyo 55
Brussels 54
Jiaxing 54
Woodbridge 53
Campinas 50
Frankfurt am Main 50
Rome 49
Salvador 49
Buffalo 46
Cagliari 45
Baghdad 44
Da Nang 44
Nuremberg 43
San Francisco 42
Johannesburg 41
Chicago 39
Guayaquil 38
Kunming 38
Warsaw 38
Guarulhos 37
Norwalk 37
Vienna 37
Hangzhou 36
Goiânia 35
Houston 35
London 35
Toronto 35
Santo André 34
Sorocaba 33
Fortaleza 32
Mexico City 32
Nairobi 32
Ankara 31
Jinan 31
Munich 31
Stockholm 31
São José dos Campos 31
Amman 30
Atlanta 30
Brooklyn 30
Chennai 30
Denver 30
Istanbul 30
Zhengzhou 30
Baku 29
Dhaka 29
Haiphong 29
Andover 28
Phoenix 28
Campo Grande 27
Recife 27
Montevideo 26
Boston 25
Montreal 25
Uberlândia 25
Betim 24
Guangzhou 24
Mountain View 24
Ribeirão Preto 24
Totale 19.284
Nome #
Artificial intelligence in the diagnosis of gastro‐entero‐pancreatic neuroendocrine neoplasms: Potential benefits and current limitations 586
Adverse Event Profile During the Treatment of Helicobacter pylori: A Real-World Experience of 22,000 Patients From the European Registry on H. pylori Management (Hp-EuReg) 296
The Cholesterol Paradox in Long-Livers from a Sardinia Longevity Hot Spot (Blue Zone) 277
Glucose-6-phosphate dehydrogenase deficiency and risk of colorectal cancer in Northern Sardinia A retrospective observational study 230
Does the longevity of the Sardinian population date back to Roman times? A comprehensive review of the available evidence 213
Amoxycillin resistance is one reason for failure of amoxycillin omeprazole treatment of Helicobacter pylori infection 203
Diet and longevity in the Blue Zones: A set-and-forget issue? 197
Abnormal gut motility in inflammatory bowel disease: an update 190
Antibiotic resistant H-pylori are extremely common in Sardinia. 181
Amoxicillin resistance is one reason for failure of amoxicillin omeprazole treatment of Helicobacter pylori infection. 180
Efficacy of a "Rescue" Ciprofloxacin-Based Regimen for Eradication of Helicobacter pylori Infection after Treatment Failures 179
Fecal Microbiota Signatures in Celiac Disease Patients With Poly-Autoimmunity 178
Active peptic ulcer disease in patients with hepatitis C virus-related cirrhosis: the role of Helicobacter pylori infection and portal hypertensive gastropathy 177
Male longevity in Sardinia, a review of historical sources supporting a causal link with dietary factors. 177
Chronic autoimmune disorders are increased in coeliac disease 174
Gut Microbiota as a Driver of Inflammation in Nonalcoholic Fatty Liver Disease 173
Glucose-6-Phosphate Dehydrogenase Deficiency Reduces Susceptibility to Cancer of Endodermal Origin 173
Microbial contamination of surfaces in the departments of Medicine and Surgery: Single center prevalence study in Sassari (Italy) [Contaminazioni microbiche di superfici di frequente contatto in reparti di medicina e chirurgia: studio monocentrico di prevalenza a Sassari] 172
Allelic imbalance and microsatellite instability in hepatitis C virus-related liver diseases. 171
Acquisition of Helicobacter pylori infection in school children in Italy. 170
A Simplified Low-Dose 10-Day Quadruple Therapy with a Galenic Formulation of Bismuth Salicylate Is Highly Effective for Helicobacter pylori Eradication 166
Characterization of chromosomal DNA profiles from Helicobacter pylori strains. Comparison of different methods: R.F.L.P., R.A.P.D. and P.F.G.E. 165
Effect of age, period and birth-cohort on the frequency of glucose-6-phosphate dehydrogenase deficiency in Sardinian adults 164
Analysis of Physical Activity Among Free-Living Nonagenarians From a Sardinian Longevous Population 161
Anti-Thyroid Peroxidase Antibodies and Male Gender Are Associated with Diabetes Occurrence in Patients with Beta-Thalassemia Major 160
Acquired Glucose-6-Phosphate Dehydrogenase Deficiency 159
Increased Frequency of Immune Thrombocytopenic Purpura in Coeliac Disease and Vice Versa: a prospective observational study 158
Twice-a-day PPI, tetracycline, metronidazole quadruple therapy with Pylera® or Lactobacillus reuteri for treatment naïve or for retreatment of Helicobacter pylori. Two randomized pilot studies 157
Twice daily (mid-day and evening) quadruple therapy for H. pylori infection in the United States 156
Altitude and prevalence of Helicobacter pylori infection in Italian children 155
Correlation between nasal mucociliary clearance time and gastroesophageal reflux disease: Our experience on 50 patients 154
Twice a day quadruple therapy for eradication of helicaobacter pylori in the elderly 154
Helicobacter pylori may play a contributory role in the pathogenesis of primary sclerosing cholangitis 153
Clinical pattern of celiac disease in a population residing in North Sardinia (Italy) 152
Twice-a-day bismuth-containing quadruple therapy for Helicobacter pylori eradication: a randomized trial of 10 and 14 days. 152
Genotypic characterization of clarithromycin-resistant Helicobacter pylori strains 151
Genomic instability in chronic viral hepatitis and hepatocellular carcinoma 150
Effect of amoxicillin resistance on the therapy of Helicobacter pylori infection. 150
A novel penicillin-binding protein(PBP-D) is involved in amoxicillin resistance in Helicobacter pylori 150
Role of routine small intestinal biopsy in adult patient with irritable bowel syndrome-like symptoms. 149
Urea breath test an rapid urease test 149
Dietary Habits, Anthropometric Features and Daily Performance in Two Independent Long-Lived Populations from Nicoya peninsula (Costa Rica) and Ogliastra (Sardinia) 148
The Rise and Fall of the Secular Trend in Body Height in Sardinia: An Age-Period-Cohort Analysis 148
Role of Probiotics in Helicobacter pylori Eradication: Lessons from a Study of Lactobacillus reuteri Strains DSM 17938 and ATCC PTA 6475 (Gastrus®) and a Proton-Pump Inhibitor 147
Coeliac Disease: Beyond Genetic Susceptibility and Gluten. A Narrative Review 146
Health properties of the Italian San Martino® mineral-rich water: A self-controlled pilot study 146
Diet, lifestyle and gender in gastro-esophageal reflux disease 146
Inclusion of Lactobacillus Reuteri in the Treatment of Helicobacter pylori in Sardinian Patients: A Case Report Series 145
Myenteric plexitis: A frequent feature in patients undergoing surgery for colonic diverticular disease 145
The Association of Childhood Asthma and Helicobacter pylori Infection in Sardinia 144
Geographical association of Helicobacter pylori infection among children in Italy. 144
Is There a Role for Probiotics in Helicobacter pylori Therapy? 143
Overweight: A Protective Factor against Comorbidity in the Elderly 142
Evolution of the dietary patterns across nutrition transition in the sardinian longevity blue zone and association with health indicators in the oldest old 142
Prevalence of lactase persistence and the performance of a new non invasive genetic test in adult Sardinian patients 142
Dyspepsia: when and how to test for Helicobacter pylori infection 140
Is there a role for gut microbiota in type 1 diabetes pathogenesis? 140
Side Effects Associated with Probiotic Use in Adult Patients with Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials 138
Amoxycillin tolerance in Helicobacter pylori. J Antimicrob Chemother 1999 138
Colonic motility in ulcerative colitis 138
Proteomic characterization of hepatitis C eradication: enzyme switch in the healing liver. 137
Risk factors associated with colonic diverticulosis among patients from a defined geographic area 136
Reactive arthritis secondary to Hafnia alvei enterocolitis. 136
A novel monoclonal antibody test to detect H-pylori antigens in human stool 135
Clinical and genetic profile of patients with seronegative coeliac disease: the natural history and response to gluten-free diet 135
Sensitivity of amoxicillin-resistant Helicobacter pylori to other penicillins 135
Amoxicillin resistant strains of Hp undergo reversible loss of resistance after storage 133
Association of Helicobacter pylori Infection with Autoimmune Thyroid Disease in the Female Sex 132
Are there endoscopic features predictive of H-pylori-related gastritis? 132
Effect of Probiotic Use on Adverse Events in Adult Patients with Inflammatory Bowel Disease: a retrospective Cohort Study 132
Explanation for variability of omeprazole amoxicillin therapy? Tolerance of H-pylori to amoxicillin. 132
Salvage therapy after two or more prior Helicobacter pylori treatment failures: the super salvage regimen. 132
Response to: Comment on “Gut Microbiota as a Driver of Inflammation in Nonalcoholic Fatty Liver Disease” 132
Artificial Intelligence for Prognosis of Gastro-Entero-Pancreatic Neuroendocrine Neoplasms 131
The Eating Habits of School Children from the Longevity Blue Zone of Sardinia: a Positive Model 131
Clustering of immunological, metabolic and genetic features in latent autoimmune diabetes in adults: evidence from principal component analysis. 131
Diabetes mellitus and Helicobacter pylori infection. 130
Acquired-multidrug resistant Helicobacter pylori: Association of high- or low-level resistance to beta-lactam antibiotics with natural transmission 129
The Elderly with Glucose-6-Phosphate Dehydrogenase Deficiency are More Susceptible to Cardiovascular Disease 129
A novel non invasive genetic test to diagnose hypolactasia in adult patients 126
Helicobacter infection in patients with HCV-chronic liver diseases 126
Risk Factors Associated with Helicobacter pylori Infection among Children in a Defined Geographic Area 126
Metagenomic Changes of Gut Microbiota following Treatment of Helicobacter pylori Infection with a Simplified Low-Dose Quadruple Therapy with Bismuth or Lactobacillus reuteri 125
Colloidal bismuth subcitrate-based twice-a-day quadruple therapy as primary or salvage therapy for Helicobacter pylori infection 125
Malattia da Reflusso Gastro-Esofageo. 125
The association of adult height with the risk of cardiovascular disease and cancer in the population of Sardinia 125
Iatrogenic immunosuppression may favour Alternaria skin lesion flares 125
Detection of helicobacter pylori infection: prospective blind comparison of invasive and non invasive methods including PCR 125
Reflux symptoms in professional opera choristers 124
Tissue transglutaminase in gastric biopsies: A marker of gastritis associated to Helicobacter pylori infection? 124
Clinical features and natural history of idiopathic peptic ulcers: a retrospective case–control study 124
Pretreatment antibiotic resistance in Hp infection 123
Interferon therapy of HCV cirrhosis reduces the incidence of HCC, and decompensation, and significantly improves survival: A 5 year comparative trial 123
Helicobacter pylori therapy: a paradigm shift 122
Helicobacter infection in sheep: Vehicle for transmission or ancestral host? 122
Is there anything to the reported association between Helicobacter pylori infection and diabetes mellitus? 121
The PNEI holistic approach in coloproctology 121
High prevalence of Helicobacter pylori infection in shepherds 121
Infezione da Helicobacter pylori. 120
Are gastric hyperplastic polyps an additional manifestation in celiac disease? Results from an observational study 120
Totale 15.397
Categoria #
all - tutte 145.037
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 145.037


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.020 0 13 12 10 13 11 54 99 97 77 134 500
2022/20232.819 286 185 90 514 234 500 2 317 439 67 116 69
2023/2024787 140 77 55 41 101 53 4 45 2 6 125 138
2024/20258.842 67 70 511 195 329 308 695 1.760 2.904 1.430 382 191
2025/202612.863 532 3.205 1.404 1.718 1.135 717 1.936 488 588 570 338 232
2026/20271.588 700 888 0 0 0 0 0 0 0 0 0 0
Totale 34.210